With cardiovascular disease and other chronic conditions like diabetes and obesity on the rise, NUS Medicine launches first of its kind Master of Science in Nutrition and Lifestyle Medicine to train more healthcare professionals in preventive medicine, focusing on lifestyle and nutrition to promote healthy ageing, lower healthcare costs, and support well-being across the lifespan.

A new study by investigators from Mass General Brigham aimed to understand if using a CPAP machine could also protect the heart and brain from cardiovascular events in people with OSA. Their findings, published in European Heart Journal, suggest that a more personalized approach for treating patients is needed—one that focuses on CPAP treatment for those who stand to gain the most, while exercising caution for those who may not benefit and could even be harmed.

A treatment commonly used for obstructive sleep apnoea (OSA), lowers the risk of serious cardiovascular events in some patients but not others, according to research published in the European Heart Journal today.

The simple daily habit of standing up more often may impact heart health for postmenopausal women, according to a new study from University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science.

Researchers at the Lewis Katz School of Medicine at Temple University have identified a new strategy that may help repair damaged heart tissue by reactivating an important developmental gene.

About The Study: The U.S. Congress enacted the Maintaining Internal Systems and Strengthening Integrated Outside Networks (MISSION) Act with the goal of improving veterans’ access to health care services. This study found that MISSION Act implementation was associated with substantial decreases in travel times among veterans who became geographically eligible for non-Veterans Affairs care. For these patients undergoing percutaneous coronary intervention or coronary artery bypass grafting, MISSION Act implementation was also associated with worsened 30-day major adverse cardiovascular events rates.

A team of researchers led by two University of Mississippi professors is working to unlock patterns and causes of the No. 1 killer of Mississippians: heart disease.

Trustworthy Artificial Intelligence for Personalised Risk Assessment, or AI4HF, is a 4-year project funded by the European Union’s Horizon Europe Framework 

AI4HF aims to co-design, develop and evaluate the first trustworthy artificial intelligence (AI) tool for personalising the care and management of patients with heart failure. 

The project brings together patients, clinicians and other stakeholders from Europe, South America and Africa with regular workshops to allow input from all 

The workshops have produced many ideas for refining AI for heart failure treatment, including increasing health and digital literacy, personalised recommendations on improving lifestyle, and social components such as involvement of carers. A new round of workshops is ongoing